Jade Biosciences Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ null, null, null, null, 67.55 ], "ebit_estimate": [ -180.36, -195.4, -220.71, -261.84, -219.46 ], "ebitda_estimate": [ -189.68, -196.21, -202.99, null, null ], "net_income_estimate": [ -172.97, -190.62, -218.36, -259.79, -217.24 ], "per_share_eps_estimate": [ -2.62, -2.61, -2.56, -2.86, -2.32 ], "eps_nri_estimate": [ -2.61, -2.61, -2.56, -2.86, -2.32 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 4.24, 2.22, 3.68, null, null ], "pretax_income_estimate": [ -173.65, -190.97, -218.33, -258.21, -231.67 ], "operating_cash_flow_per_share_estimate": [ -2.28, -2.28, -2.04, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ -53.1, -70.96, -73.11, null, null ], "gross_margin_estimate": [ null, null, null, null, 85 ], "operating_cash_flow_estimate": [ -131.73, -131.73, -117.87, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0 ], "long_term_growth_rate_mean": 12.03, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 12.06, "future_eps_nri_estimate_growth": 12.03, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -23.6, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -19.28, "future_pretax_income_estimate_growth": -19.38, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ null, null, null, null, null, null, null, null ], "ebit_estimate": [ -43.83, -45.37, -47.37, -48.4, -50.17, -51.63, -53.13, null ], "ebitda_estimate": [ -45.99, -48.69, -51.57, null, null, null, null, null ], "net_income_estimate": [ -42.11, -43.79, -45.92, -45.47, -47.3, -48.77, -50.27, null ], "per_share_eps_estimate": [ -0.64, -0.66, -0.69, -0.68, -0.7, -0.7, -0.72, null ], "eps_nri_estimate": [ -0.64, -0.66, -0.69, -0.68, -0.7, -0.7, -0.72, -0.75 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -42.23, -44.01, -46.3, -46.25, -48.5, -50.25, -52, null ], "operating_cash_flow_per_share_estimate": [ -0.54, -0.57, -0.6, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null, null ], "operating_cash_flow_estimate": [ -31.2, -32.93, -34.67, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null, null ], "long_term_growth_rate_mean": 12.03, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 12.06, "future_eps_nri_estimate_growth": 12.03, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -23.6, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -19.28, "future_pretax_income_estimate_growth": -19.38, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }